- Home
- LPL vs CERT Comparison
LPL vs CERT Comparison
Compare LPL & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPL
- CERT
- Stock Information
- Founded
- LPL 1985
- CERT 2008
- Country
- LPL South Korea
- CERT United States
- Employees
- LPL N/A
- CERT N/A
- Industry
- LPL Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- LPL Technology
- CERT Technology
- Exchange
- LPL Nasdaq
- CERT Nasdaq
- Market Cap
- LPL 2.9B
- CERT 2.3B
- IPO Year
- LPL 2004
- CERT 2020
- Fundamental
- Price
- LPL $3.11
- CERT $10.97
- Analyst Decision
- LPL Sell
- CERT Buy
- Analyst Count
- LPL 2
- CERT 6
- Target Price
- LPL N/A
- CERT $15.60
- AVG Volume (30 Days)
- LPL 195.4K
- CERT 1.7M
- Earning Date
- LPL 05-15-2025
- CERT 05-05-2025
- Dividend Yield
- LPL N/A
- CERT N/A
- EPS Growth
- LPL N/A
- CERT N/A
- EPS
- LPL N/A
- CERT N/A
- Revenue
- LPL $18,624,457,609.00
- CERT $394,498,000.00
- Revenue This Year
- LPL N/A
- CERT $11.47
- Revenue Next Year
- LPL N/A
- CERT $9.03
- P/E Ratio
- LPL N/A
- CERT N/A
- Revenue Growth
- LPL 23.70
- CERT 9.37
- 52 Week Low
- LPL $2.43
- CERT $8.64
- 52 Week High
- LPL $4.86
- CERT $17.76
- Technical
- Relative Strength Index (RSI)
- LPL 52.34
- CERT 40.34
- Support Level
- LPL $3.08
- CERT $11.15
- Resistance Level
- LPL $3.19
- CERT $11.75
- Average True Range (ATR)
- LPL 0.06
- CERT 0.39
- MACD
- LPL -0.00
- CERT -0.06
- Stochastic Oscillator
- LPL 43.25
- CERT 17.83
About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.